Océanie · Bourse & Finance · The Motley Fool Australia

This ASX biotech could rise almost 50%, Morgans says

Publié par The Motley Fool Australia · Australie il y a 4 h

Turning science into contracts could unlock value for this company. The post This ASX biotech could rise almost 50%, Morgans says appeared first on The Motley Fool Australia.

Lire l'article complet sur The Motley Fool Australia Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.fool.com.au)

This ASX biotech could rise almost 50%, Morgans says

À lire aussi

Breaking: Planning decision to extend life of mega coal mine saves 1,500 jobs

StockTake: Imagion clears key hurdle for Phase 2 trial

State's surplus hits $4.2b

REI Super names chief executive

Inside the race for AI recommendations: the Melbourne teen cracking the code

Ask Paul: Mum's in aged care, can we keep the family home?

This ASX biotech could rise almost 50%, Morgans says

Partager

À lire aussi

Breaking: Planning decision to extend life of mega coal mine saves 1,500 jobs

StockTake: Imagion clears key hurdle for Phase 2 trial

State's surplus hits $4.2b

REI Super names chief executive

Inside the race for AI recommendations: the Melbourne teen cracking the code

Ask Paul: Mum's in aged care, can we keep the family home?